Annual Report 2021

CORPORATE CALENDAR OF 2021 4 The United Laboratories International Holdings Limited Annual Report 2021 • Zhuhai United Laboratories was selected to be one of the “Top 100 Enterprises of Synthetical Competitiveness Index of Pharmaceutical Industry in 2020-2021” by CHEO (China Health Ecology Organization). • Zhuhai United Laboratories was awarded the “Outstanding Enterprise Brand of Exported Bulk Medicine” by China Pharmaceutical Industry Association. • Twelve production lines of The United Animal Healthcare passed the acceptance by the Veterinary Bureau of Inner Mongolia Agriculture and Animal Husbandry Department according to the new edition of GMP qualified production lines for veterinary drugs. • The United Laboratories won all the bid of six groups of insulin products in the Sixth Batch of National Centralized Procurement of Pharmaceuticals (specializing in insulin). • Quality Inspection Center of Zhuhai United Laboratories has been accredited as a national laboratory by China National Accreditation Service for Conformity Assessment (CNAS) for 11 consecutive years. • According to the latest ESG rating report from MSCI (Morgan Stanley Capital International), The United Laboratories (03933.HK ) has been rated as grade A and its ESG rating has been improved for the past two consecutive years. • The United Bio-Technology (Hengqin) Co., Ltd. was awarded “Emerging Enterprise of Top 50 Innovative Biotechnology Enterprises in the Fourth Guangdong-Hong Kong-Macao Greater Bay Area”. • The United Laboratories won the “Best ESG Award” of the 5th China Excellence IR. September October November December